Zach Cregger's horror reboot is closing in on a historic milestone, outperforming a major Disney franchise on a fraction of the budget.
The Resident Evil movie 2026 release has stopped being just a hit and started behaving like a statistical glitch in the horror market. Sitting at 42 days in theaters, the title has pulled in $154.9 million domestically, a number that puts it within shouting distance of a massive industry landmark. It is now less than $25 million away from overtaking the North American total for Star Wars: The Mandalorian & Grogu, a feat that sounds almost absurd given the genre difference.
What makes this run stand out is the sheer cost disparity. This reboot came in at a $75 million production budget, while the Disney Star Wars entry required a $165 million investment to get to the same screen. Now in its sixth week, the film is still holding steady in over 2,000 North American locations. This sustained pull is not a flash in the pan; it is a durable commercial force that refuses to fade into the background noise of a crowded release window.
The Numbers Behind the Reboot
The weekly data shows a natural, if slowing, decline in grosses. On its sixth Thursday, the film took in $292,000 across 2,148 screens, marking a 32.2% drop from the previous week’s Thursday. Yet the cumulative total remains stubbornly strong. The title has already cleared the $150 million domestic hurdle, a threshold that many mid-budget films never touch during their entire theatrical life, let alone on a weekly basis.
The international numbers are even more compelling. The production has banked $230.3 million overseas, pushing the worldwide total to $385.2 million. Projections point to a near-certainty of crossing the $400 million global mark. This cross-border resonance proves the film has connected with viewers far beyond its initial domestic base. It is no longer just a North American success story but a genuine global commercial event that defies the usual geographic limitations of horror.

A Budget Defying the Odds
The real story here is financial efficiency. With a $75 million production cost, the film has already generated more than double its investment domestically. Comparing it to The Mandalorian & Grogu is not just about who made more money; it is about return on investment. The Disney film spent over twice as much to achieve a lower domestic total, a fact that stings in the current climate. This level of efficiency is rare in the modern blockbuster era, where margins are razor-thin and expectations are sky-high.
The film has already beaten the Star Wars title at the worldwide box office. Beating it in North America would complete a significant professional victory for the production team. It would prove that a focused, lower-budget horror film can outperform a massive franchise entry. This shift in power dynamics is one of the most interesting developments in the current theatrical landscape, signaling that audiences are voting with their wallets for substance over spectacle.

Zach Cregger's Vision
Director Zach Cregger has crafted a film that feels both intimate and epic. The plot follows a courier who becomes trapped in a remote hospital during an outbreak. He must navigate through mutated creatures to survive. This contained setting allows for high tension without the need for sprawling action sequences. It is a classic horror structure executed with modern flair, proving that you do not need a billion-dollar budget to create a sense of scale and danger.
The film has been running in theaters since September 17. Its longevity is a testament to its quality. Audiences are returning for a second and third viewing, a behavior that is increasingly rare in an era of instant digital access. This word-of-mouth momentum is what keeps the weekly numbers strong. It is not relying on hype or marketing spend alone. It is relying on the sheer entertainment value of the experience, which is the only currency that matters in the long run.

The Horror Genre's Golden Age
This success does not happen in a vacuum. 2026 is shaping up to be a record year for the horror genre. The 20 wide-release horror films released this year have contributed roughly $3 billion to the worldwide box office. Nearly half of that comes from domestic receipts. This level of financial performance is unprecedented for a genre that is often overlooked by major studios, who tend to prioritize action and comedy for their biggest slots.
The trend is clear. Audiences are hungry for high-quality, auteur-driven horror. The success of films like Sinners and now Resident Evil shows that viewers are willing to support bold, personal visions. The democratization of filmmaking tools has allowed more diverse voices to enter the space. This has led to a richer, more varied slate of options for moviegoers, proving that the genre is no longer a niche but a mainstream driver of box office revenue.
What Comes Next
The film is now in the home stretch of its theatrical run. If it passes the $177.7 million domestic mark, it will join an elite list of horror films. This milestone would cement its place in cinema history. It would also signal to studios that they can take more risks with their mid-budget slates. The financial safety net of a strong domestic performance is invaluable, providing a buffer against the volatility of international markets and streaming expectations.
The production team should be celebrated for this achievement. They delivered a film that is both critically acclaimed and commercially dominant. This is a rare combination. The coming weeks will determine if it crosses that final threshold. Regardless of the final number, the Resident Evil movie 2026 has already made its mark. It has changed the conversation about what a horror film can achieve, setting a new standard for the genre in the years to come.
Frequently asked questions

Keep subscribing to Bùi MaiHer next filing reaches you the moment it publishes, on her own subdomain.
Subscribe
